U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396194) titled 'Ankylosing Spondylitis' on Feb. 01.
Brief Summary: The goal of this observational study is to measure the serum level of cytokines IL-17, IL-38,IL-41, and gene expression of HLA-B27 gene in ankylosing spondylitis patients and healthy control group.
The main question it aims to answer is:
Does the disease activity, severity, serum level of cytokines (IL-17, IL-38, and IL-41) are affected by the HLA-b27 gene positivity?
Researchers will compare the serum level of cytokines IL-17, IL-38,IL-41, and gene expression of HLA-B27 gene in ankylosing spondylitis patients and healthy control group to see if there significant differences in s...